Australian scientists announce they have made a breakthrough in Chronic Fatigue Syndrome testing, now looking for partners to bring a diagnostic test to market.
An ABC radio interview with Australian scientists at Queensland’s Griffith University reveals they have identified new markers on white blood cells which can be used to screen patients. Patient Lyn Wilson, Professor Don Staines and Professor Sonya Marshall Gradisnik are interviewed.
Several published and as-yet-unpublished studies contributed to this stage, see the abstract for the study, ‘A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis’.
The study, conducted on 23 CFS/ME patients, 11 untreated MS patients, and 30 nonfatigued controls. In CFS/ME patients, a marker called CD127 was significantly decreased on all subsets of CD8+ T cells. PSGL-1 was significantly reduced.
To read the rest of this story, click on the link below: